# Pediatric Gastroesophageal Reflux Disease: Developing Drugs for Treatment Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/pediatric-gastroesophageal-reflux-disease-developing-drugs-for-treatment-guidance-for-industry/eed3bedd-c895-4ca2-bd44-b1c92b786f14

> FDA guidance document: Pediatric Gastroesophageal Reflux Disease: Developing Drugs for Treatment Guidance for Industry. Issue date: October 26, 2017. Get complete insights and analysis.

---

## Details

- Title: Pediatric Gastroesophageal Reflux Disease: Developing Drugs for Treatment Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2017-10-26
- Comment Close Date: 2018-01-26
- Last Changed: 2024-04-11
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2017-D-5912">FDA-2017-D-5912</a>

## Related Documents

- [Symptomatic Nonerosive Gastroesophageal Reflux Disease:  Developing Drugs for Treatment: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/symptomatic-nonerosive-gastroesophageal-reflux-disease-developing-drugs-for-treatment-draft-guidance-for-industry/a7edda76-4160-401c-a7b4-f752b268fd5d)
- [Pediatric Inflammatory Bowel Disease:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/pediatric-inflammatory-bowel-disease-developing-drugs-for-treatment/f199b979-79a2-47a4-99e4-b55e181a268d)
- [Stimulant Use Disorders: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/stimulant-use-disorders-developing-drugs-for-treatment/396da81b-e089-444c-9781-b40a43a1cff2)